Overweight and obesity are not associated with worse clinical outcomes in COVID-19 patients treated with fixed-dose 6 mg dexamethasone.

In the dexamethasone cohort, the percentage of ICU-admission and/or in hospital death was higher in patients with normal weight than in patients with overweight and patients with obesity (33% vs 26% vs 21%; p for trend = 0.07), though this difference between groups did not reach statistical significance (Fig. 2 ).

also in 111,027 other papers